# Pilot Study Of Unrelated UCB Transplant for Non-Malignant Hematologic Conditions

> **NCT00003336** · PHASE2 · COMPLETED · sponsor: **Case Comprehensive Cancer Center** · enrollment: 6 (actual)

## Conditions studied

- Leukemia
- Myelodysplastic Syndromes
- Myelodysplastic/Myeloproliferative Diseases

## Interventions

- **BIOLOGICAL:** anti-thymocyte globulin
- **DRUG:** busulfan
- **DRUG:** cyclophosphamide
- **DRUG:** melphalan
- **DRUG:** methylprednisolone
- **PROCEDURE:** bone marrow ablation with stem cell support
- **PROCEDURE:** umbilical cord blood transplantation
- **RADIATION:** radiation therapy

## Key facts

- **NCT ID:** NCT00003336
- **Lead sponsor:** Case Comprehensive Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1998-01
- **Primary completion:** 2005-12
- **Final completion:** 2006-02
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2010-06-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00003336

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00003336, "Pilot Study Of Unrelated UCB Transplant for Non-Malignant Hematologic Conditions". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00003336. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*